Tuesday, November 30, 2021

[ASAP] Bioengineering of Beta Cells with Immune Checkpoint Ligand as a Treatment for Early-Onset Type 1 Diabetes Mellitus

TOC Graphic

ACS Nano
DOI: 10.1021/acsnano.1c07538


from ACS Nano: Latest Articles (ACS Publications) https://ift.tt/3lmMd7b
via IFTTT
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)